Discover 1,271 paid clinical trials in Surprise, Arizona. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,271
Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer
for
Intermediate Risk Non-Muscle Invasive Bladder Cancer
Location: Phoenix AZ, Tucson AZ, Murrieta CA, Orange CA,
Sponsor: Ferring Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06510374
Phase3, Recruiting
Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial
for
Metastatic Digestive System Neuroendocrine Tumor G1,
Location: Phoenix AZ, Tucson AZ, Albuquerque NM,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05773274
Phase2, Recruiting
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
for
NSCLC (Advanced Non-small Cell Lung Cancer)
Location: Phoenix AZ, La Jolla CA, Irvine CA, Sacramento CA,
Sponsor: BlossomHill Therapeutics
Sex: All
Age: 18+
Code: NCT06706076
Phase1, Phase2, Recruiting
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
for
Solid Tumors
Location: Phoenix AZ, Santa Monica CA, Palo Alto CA, Houston TX,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT06179160
Phase1, Recruiting
Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
for
Glioblastoma, Recurrent Glioblastoma, GBM
Location: Phoenix AZ, Salt Lake City UT, Aurora CO,
Sponsor: CarThera
Sex: All
Age: 18+
Code: NCT05902169
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Phoenix AZ, Irvine CA, Orange CA, Beverly Hills CA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07518186
Phase3, Recruiting
A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
for
Meningioma
Location: Phoenix AZ, Santa Monica CA, San Antonio TX, Houston TX,
Sponsor: Exelixis
Sex: All
Age: 18+
Code: NCT07428616
Phase2, Recruiting
Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy
for
Anaplastic Large Cell Lymphoma, ALK-Negative,
Location: Phoenix AZ, Tucson AZ, Irvine CA, Orange CA, Duarte CA,
Sponsor: Eastern Cooperative Oncology Group
Sex: All
Age: 18 - 70+
Code: NCT06724237
Phase3, Recruiting
Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
for
Recurrent Glioblastoma, IDH-Wildtype,
Location: Phoenix AZ, La Jolla CA, Duarte CA, Aurora CO,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05432804
Phase1, Phase2, Recruiting
A Phase 1/2 Study of the Safety and Tolerability of MT-125 in GBM Patients
for
Glioblastoma (GBM)
Location: Phoenix AZ, Rochester MN, Jacksonville FL
Sponsor: Myosin Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT07185880
Phase1, Phase2, Recruiting
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Phoenix AZ, Irvine CA, Duarte CA, Los Angeles CA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07258511
Phase3, Recruiting
A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
for
Pancreatic Ductal Adenocarcinoma (PDAC)
Location: Phoenix AZ, St Louis MO, Rochester MN, Jacksonville FL,
Sponsor: BicycleTx Limited
Sex: All
Age: 18+
Code: NCT07450859
Phase2, Recruiting
A Study Investigating Coagadex in the Treatment AFXD Associated With AL Amyloidosis
for
Acquired Factor X Deficiency
Location: Phoenix AZ, Rochester MN
Sponsor: Kedrion S.p.A.
Sex: All
Age: 18 - 70
Code: NCT06963216
Phase3, Recruiting
Safety and Efficacy Study of TX103 CAR-T Cell Therapy for Recurrent or Progressive Grade 4 Glioma.
for
High-grade Glioma, WHO Grade â…£ Glioma
Location: Phoenix AZ, Rochester MN, Jacksonville FL
Sponsor: Tcelltech Inc.
Sex: All
Age: 18 - 70+
Code: NCT06482905
Phase1, Recruiting
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
for
Non-small Cell Lung Cancer
Location: Phoenix AZ, Irvine CA, Duarte CA, Grand Junction CO,
Sponsor: Canadian Cancer Trials Group
Sex: All
Age: 18+
Code: NCT06686771
Phase3, Recruiting
A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer
for
Colorectal Cancer
Location: Phoenix AZ, Los Angeles CA, Lone Tree CO, Temple TX,
Sponsor: Ono Pharmaceutical Co., Ltd.
Sex: All
Age: 18+
Code: NCT06948448
Phase2, Recruiting
Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
for
Heart Failure - NYHA II - IV
Location: Phoenix AZ, La Jolla CA, Torrance CA, Los Angeles CA,
Sponsor: Boston Scientific Corporation
Sex: All
Age: 18+
Code: NCT07069738
Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
for
Pancreatic Cancer, PDAC,
Location: Phoenix AZ, Las Vegas NV, La Jolla CA, Los Angeles CA,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT07252232
Phase3, Recruiting
A First-in-Human Study of YL217 in Patients With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Phoenix AZ, Santa Monica CA, San Antonio TX, Houston TX,
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.
Sex: All
Age: 18+
Code: NCT06859762
Phase1, Recruiting
Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer
for
Locally Advanced Adrenal Cortical Carcinoma,
Location: Phoenix AZ, La Jolla CA, Madera CA, Aurora CO,